62 (PB050): ORIC-114, a highly selective, brain penetrant EGFR and HER2 inhibitor, demonstrates best-in-class properties against Exon 20 insertions and other atypical EGFR mutations

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2024-10, Vol.211, p.114589, Article 114589
Main Authors: Junttila, M., Repellin, C.E., Warne, R., Long, J.E., Sambucetti, L., Ashley, P., Andreatta, G., Baik, J., Salaniwal, S., Colas, C., Romero, A., Soroceanu, L., Patel, R., Maneval, E. Chow, Multani, P.S., Daemen, A., Friedman, L.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
DOI:10.1016/j.ejca.2024.114589